CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 4 Option exercise Chief Financial Officer acquired 24,336 shares (option exercise)
- SC 13D Stake Beneficial Ownership Report
- 4 Option exercise President and CEO acquired 10,000 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 4 Open-market buy VP of Finance and Controller bought 7,387 shares at an average $4.00 ($29,553)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy VP of Finance and Controller bought 1,136 shares at $2.69 ($3,056)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Legal Officer bought 6,127 shares at $2.69 ($16,482)
Page 13 of 17 · 326 filings